A detailed history of Ever Source Wealth Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 282 shares of AUPH stock, worth $2,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
282
Previous 126 123.81%
Holding current value
$2,349
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$5.32 - $7.33 $829 - $1,143
156 Added 123.81%
282 $2,000
Q2 2024

Aug 13, 2024

BUY
$4.81 - $5.78 $129 - $156
27 Added 27.27%
126 $0
Q1 2024

Jun 11, 2024

BUY
$4.93 - $9.31 $488 - $921
99 New
99 $0

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.